Esperion Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ann Arbor, MI
SEC filing record 1 source field available
Fiscal year end
31 December
Esperion Therapeutics, Inc. has filed 951 SEC EDGAR filings since 07 May 2008

SEC filing history

Showing 776-800 of 950 matching filings.

Per page
25
Current page
32
4

FORM 4 -

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35986

144 filing

Filing date
08 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Apr 2015
Reporting date
28 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35986

DEF 14A

Filing date
01 Apr 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87536

SC 13G

Filing date
27 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87536

SCHEDULE 13D/A FOR ESPERION THERAPEUTICS, INC. BY DOMAIN PARTNERS VII, L.P.

Filing date
25 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Mar 2015
Reporting date
20 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87536

SC 13D/A

Filing date
24 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Mar 2015
Reporting date
19 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Mar 2015
Reporting date
18 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Mar 2015
Reporting date
18 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Mar 2015
Reporting date
18 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
19 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-201198

424B5

Filing date
19 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3MEF File 333-202859

S-3MEF

Filing date
18 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-201198

424B5

Filing date
17 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
17 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .